Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows

Pfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.

from Health and Science https://ift.tt/Hco4pl8
https://ift.tt/vyJ5LbP
https://ift.tt/A16WQhO